Skip to content
← Back to browse
KIDNEY Publication-derived

Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis

Source Takasato et al., 2015 · Murdoch Childrens Research Institute, The Royal Children's Hospital Melbourne · 10.1038/nature15695

👤 Minoru Takasato, Pei X. Er, Han S. Chiu, Barbara Maier, Gregory J. Baillie, Charles Ferguson, Robert G. Parton, Ernst J. Wolvetang, Matthias S. Roost, Susana M. Chuva de Sousa Lopes, Melissa H. Little ⏱ 27 days 📋 5 phases 🧫 Human iPSC

Abstract

This protocol generates complex kidney organoids from human induced pluripotent stem cells (iPSCs) that contain multiple nephron lineages and supporting tissues. The organoids model human nephrogenesis and develop functional proximal tubules capable of endocytosis and response to nephrotoxic compounds.

Cell source
Human iPSC
Application
Disease modeling, Developmental study, Drug screening (nephrotoxicity)

Protocol overview

14 steps across 5 phases

iPSC Expansion and Monolayer Culture Preparation -14 to 0
  1. 1 Maintain undifferentiated human iPS cells on feeder layer
  2. 2 Passage cells onto Matrigel and establish monolayer
Monolayer Differentiation to Intermediate Mesoderm 0 to 7
  1. 3 Initiate Wnt signaling with CHIR99021
  2. 4 Add FGF9 and heparin to induce differentiation
  3. 5 Optional: Add retinoic acid or RA receptor antagonist
  4. 6 Collect and dissociate cells at day 7
3D Organoid Culture and Nephrogenesis Induction 7 to 27
  1. 7 Form cell aggregates (pellets) on Transwell membrane
  2. 8 Apply CHIR99021 pulse to trigger nephrogenesis
  3. 9 Culture organoids with FGF9 and heparin
  4. 10 Culture organoids in basal medium for final maturation
Alternative: Monolayer Culture for Lineage Optimization 0 to 16
  1. 11 Culture cells in monolayer with FGF9 and heparin
  2. 12 Culture monolayer cells in basal medium
Functional Analysis and Maturation Assessment 17 to 18
  1. 13 Assess proximal tubule endocytosis capacity
  2. 14 Test nephrotoxicity response to cisplatin

Full SOP

🔬

Create a free account to access this protocol

Join OrganMatch to unlock step-by-step procedures, reagent concentrations, QC checklists, and downloadable batch record templates.

Create free account

Already registered? Log in

Attribution

This SOP was authored by Organthis based on the published method in Takasato et al., 2015. The originating laboratory holds no rights in this SOP and has not endorsed it unless marked Verified.

This wording is awaiting legal review.

Something wrong with this entry? Report an issue with this protocol

Need a commercial licence?
Use this protocol in your therapeutic or diagnostic pipeline.
Request Commercial Licence